title: Aclarubicin in the treatment of de-novo acute myelocytic leukaemia.
authors.affiliation: Department of Medicine, Clinical Hospital Center, Rebro, Zagreb, Yugoslavia.
authors.forename: B
authors.initials: B
authors.lastname: Labar
authors.forename: D
authors.initials: D
authors.lastname: Nemet
authors.forename: H
authors.initials: H
authors.lastname: Minigo
authors.forename: V
authors.initials: V
authors.lastname: Bogdanić
authors.forename: B
authors.initials: B
authors.lastname: Jaksić
authors.forename: M
authors.initials: M
authors.lastname: Malesević
authors.forename: M
authors.initials: M
authors.lastname: Mrsić
mesh_terms: D015250:Aclarubicin / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic
chemical_list: D015250:Aclarubicin; D003630:Daunorubicin